1 2 3 4 5 Next
Company news
Nature Vision Inc., Brainerd, received a notice from the Nasdaq Stock Market indicating that the company is in violation of the minimum bid price requirement for continued listing, as the bid price of its common stock closed below $1 per share for 30 consecutive days. (Wed, 01 Oct 2008 00:55:47 GMT)
Saliva proteins could help detection of oral cancer
( American Association for Cancer Research ) Clinicians could detect oral squamous cell carcinoma, a form of oral cancer, using a simple test that detects proteins in saliva, according to a report in the Oct. 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. This work was led by David T. Wong, D.M.D., D.M.Sc., professor and associate dean for ... (Wed, 01 Oct 2008 04:12:28 GMT)
New screening, treatments in works for ovarian cancer
Down the hall from his office in the Magee Womens Research Institute on Craft Avenue in Oakland, Thomas P. (Wed, 01 Oct 2008 04:20:19 GMT)
Saliva Proteins Could Help Detection of Oral Cancer
Clinicians could detect oral squamous cell carcinoma, a form of oral cancer, using a simple test that detects proteins in saliva, according to a report in the October 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. This work was led by David T. Wong, D.M.D., D.M.Sc., professor and associate dean for research, at the University of California, ... (Wed, 01 Oct 2008 04:21:17 GMT)
Spit proteins could lead to oral cancer test: study
A simple screen of proteins in human saliva was able to accurately detect a common type of oral cancer, a finding that may lead to a painless new diagnostic test, U.S. researchers said on Wednesday. (Wed, 01 Oct 2008 04:32:59 GMT)
Could Saliva One Day Detect Oral Cancer?
What if a saliva test could detect mouth cancer? Researchers are taking the next step in making that a possibility. (Wed, 01 Oct 2008 05:14:16 GMT)
QIAGEN Acquires Biosystems Business From Biotage
VENLO, The Netherlands, Oct. 1, 2008 -- QIAGEN N.V. today announced that it has acquired all assets related to the Biosystems business from Biotage AB, a publicly listed developer, manufacturer and distributor of products for genetic analysis and medicinal chemistry headquartered in Uppsala, Sweden. (Wed, 01 Oct 2008 06:00:00 GMT)
QIAGEN Acquires Biosystems Business from Biotage
Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ------------------------------ -------------- (Wed, 01 Oct 2008 06:20:10 GMT)
Make reservation to attend medical research conference next week
A Tucson conference Monday and Tuesday will focus on getting lifesaving medicines to the public more quickly. (Wed, 01 Oct 2008 07:11:32 GMT)
Safeway Launches 8th Annual Breast Cancer Fundraising Initiative
Safeway Inc. (NYSE:SWY), one of North America's largest corporate supporters of cancer research and treatment, today launched a month-long campaign to further breast cancer research, raise awareness and help breast cancer patients find the best options available to address their specific needs. The company initiative will highlight the need for women to have access to new and innovative ... (Wed, 01 Oct 2008 08:30:49 GMT)
New genes linked to gout
Researchers have identified two new genes - and confirmed the role of a third gene - associated with increased risk of higher levels of uric acid in the blood, which can lead to gout, a common, painful form of arthritis. Combined, the three genetic variations were associated with up to a 40-fold increased risk in developing gout. The findings suggest that genetic testing could one day be used to ... (Wed, 01 Oct 2008 08:47:39 GMT)
Drug Discovery Research Turns To Biomarkers
The total drug discovery market in Western Europe was worth $17.40 billion in 2007, and Frost & Sullivan expects this to grow at a compound annual growth rate of 13.5% to reach $42.08 billion by 2014 (Wed, 01 Oct 2008 08:54:28 GMT)
BIOTECHNICA 2008 Exhibitor Profiles
HANNOVER, Germany----BIOTECHNICA 2008 takes place October 07, 2008 - October 09, 2008 at the Deutsche Messe Exhibition Grounds in Hannover, Germany. Listed below are the BIOTECHNICA 2008 exhibitor profiles. (Wed, 01 Oct 2008 09:05:00 GMT)
BIOTECHNICA 2008 Exhibitor Profiles
BIOTECHNICA 2008 takes place October 07, 2008 - October 09, 2008 at the Deutsche Messe Exhibition Grounds in Hannover, Germany. Listed below are the BIOTECHNICA 2008 exhibitor profiles. (Wed, 01 Oct 2008 09:26:52 GMT)
Dreams taking shape
Dr. Glover O.L. Johnson has a dream for Cleveland — to establish a biomedical research institute that rivals that best medical schools in the United States. On Saturday at the ZaZa Hotel in Houston, he shared his dream with 350 or so people at a gala to benefit the Southeast Texas Biomedical Research Institute (SETBRI). (Wed, 01 Oct 2008 10:51:16 GMT)
Applied Biosystems Debuts New SOLiD(TM) 3 System Expected to Enable $10K Genome
FOSTER CITY, Calif.----Applied Biosystems today announced a new genomic analysis platform, the SOLiD™ 3 System, that is expected to enable scientists to sequence a human genome for approximately $10,000. (Wed, 01 Oct 2008 11:30:00 GMT)
U.S. Food And Drug Administration Selects Applied Biosystems To Provide Mass Spectrometry Instrument Systems For Food ...
Applied Biosystems Inc. today announced that the U.S. Food and Drug Administration has purchased seven of the company's 4000 QTRAP Systems for the analysis of potential harmful pesticides in the U.S. food supply. (Wed, 01 Oct 2008 11:49:46 GMT)
Applied Biosystems Debuts New SOLiD(TM) 3 System Expected to Enable $10K Genome
Applied Biosystems (NYSE:ABI) today announced a new genomic analysis platform, the SOLiD(TM) 3 System, that is expected to enable scientists to sequence a human genome for approximately $10,000. Significant cost-reduction and productivity enhancements have been built into the company's latest ultra-high-throughput genomic analysis platform, enabling researchers to dramatically drive down the ... (Wed, 01 Oct 2008 11:57:51 GMT)
Affymetrix and Medical Prognosis Institute Collaborate to Develop Cancer Treatment Products
SANTA CLARA, Calif.----Affymetrix Inc. and Medical Prognosis Institute A/S , a leading cancer diagnostic development company based in Denmark, today announced that they have signed a Powered by Affymetrix™ agreement. (Wed, 01 Oct 2008 12:00:00 GMT)
Healthy honey bees is goal of multi-institutional research team
WEST LAFAYETTE — Greg Hunt, a Purdue apicultural researcher and geneticist, is collaborating with 19 scientists from around the country to launch an in-depth study of bees' behavior, lives, illnesses and deaths to define the syndrome known as colony collapse disorder (CCD). The investigators' goal is to find ways to restore bee colonies and keep them safe. (Wed, 01 Oct 2008 12:00:16 GMT)
U.S. Food And Drug Administration Selects Applied Biosystems To Provide Mass Spectrometry Instrument Systems For Food ...
Applied Biosystems Inc. today announced that the U.S. Food and Drug Administration has purchased seven of the company's 4000 QTRAP Systems for the analysis of potential harmful pesticides in the U.S. food supply. (Wed, 01 Oct 2008 12:10:26 GMT)
Affymetrix and Medical Prognosis Institute Collaborate to Develop Cancer Treatment Products
Affymetrix Inc. (Nasdaq:AFFX) and Medical Prognosis Institute A/S (MPI), a leading cancer diagnostic development company based in Denmark, today announced that they have signed a Powered by Affymetrix(TM) (PbA) agreement. With this agreement, MPI gains non-exclusive access to Affymetrix microarray technology to develop and commercialize drug sensitivity prediction and prognostic products for ... (Wed, 01 Oct 2008 12:16:40 GMT)
Oerlikon Leybold Vacuum Aids Development of Tool To Identify Rare Cancer Cells
As part of a comprehensive R&D effort to develop an analytic tool to assist in accurately identifying leukemia stem cells, Oerlikon Leybold Vacuum is supporting the StemSpec R&D project at the University of Toronto with a TURBOVAC SL turbomolecular vacuum pump and a fore vacuum pump, and advising researchers about the use of the pumps. (Wed, 01 Oct 2008 12:46:48 GMT)
First-of-its-kind cancer conference planned Oct. 11 for Arizona's Native Americans
( The Translational Genomics Research Institute ) The Arizona Myeloma Network, working with other non-profit groups throughout Arizona, is planning its first Fort Defiance Cancer Awareness and Advocacy Conference focusing on the health challenges facing Native Americans. (Wed, 01 Oct 2008 13:04:50 GMT)
FDA funds 10-year modernization project
WASHINGTON, Oct. 1 (UPI) -- The U.S. Food and Drug Administration has selected 10 contractors to receive up to $2.5 billion to help modernize bioinformatics technology. (Wed, 01 Oct 2008 13:31:22 GMT)
FDA funds 10-year modernization project
The U.S. Food and Drug Administration has selected 10 contractors to receive up to $2.5 billion to help modernize bioinformatics technology.The 10-year contract is the cornerstone of the FDA's Information Technology for the 21st Century bioinformatics initiative, an extensive IT modernization program encompassing data management, data warehousing, IT infrastructure and IT security. This contract ... (Wed, 01 Oct 2008 13:37:22 GMT)
GenomeQuest Announces Integration of GenomeQuest(TM) 5.0 with Invitrogen's Vector NTI Advance(TM) for Genomic Sequence ...
GenomeQuest and Invitrogen today announced that the GenomeQuest(TM) 5.0 web-based sequence search, analysis and data management platform is now interoperable with Invitrogen's Vector NTI Advance(TM) desktop sequence analysis solution. (Wed, 01 Oct 2008 13:58:21 GMT)
Affymetrix licenses genetic analysis technology
Affymetrix Inc., which makes the GeneChip system for genetic data analysis, said Wednesday it licensed technology to Denmark-based Medical Prognosis Institute for an undisclosed amount. (Wed, 01 Oct 2008 15:01:26 GMT)
Liane Russell - Oak Ridge icon
The Atomic Energy Commission, on Jan. 1, 1947, officially took responsibility for the nation's atomic energy program from the Manhattan Project's General Groves and Colonel Nichols. This change resulted in Oak Ridge being changed from the central location for managing the entire atomic energy programs to being a smaller field office. Yet, Oak Ridge remained central to nuclear energy ... (Wed, 01 Oct 2008 15:24:28 GMT)
Developer Diaries
Profiles of programmers, descriptions of developers. (Wed, 01 Oct 2008 17:34:23 GMT)
Fat Gene Linked to Colon Cancer
Title: Fat Gene Linked to Colon Cancer Category: Health News Created: 10/1/2008 Last Editorial Review: 10/1/2008 (Wed, 01 Oct 2008 19:28:02 GMT)
7th Annual Charlotte Biotechnology Conference to feature Dr. Roger Newton, co-discoverer of Lipitor(R) and founder of ...
CHARLOTTE, N.C.----The University of North Carolina at Charlotte and the Charlotte Research Institute will present the 7th Annual Charlotte Biotechnology Conference taking place at the Barnhardt Student Activities Center on October 28, 2008. (Wed, 01 Oct 2008 19:43:00 GMT)
Stone Bond Technologies Selects The Planet for Software Test Bed
HOUSTON, Sept. 29, 2008 – The Planet, the global leader in IT hosting , today announced that Stone Bond Technologies ( www.stonebond.com ) has selected the company as the core platform for its software test bed. (Wed, 01 Oct 2008 19:44:44 GMT)
7th Annual Charlotte Biotechnology Conference to feature Dr. Roger Newton, co-discoverer of Lipitor(R) and founder of ...
The University of North Carolina at Charlotte and the Charlotte Research Institute will present the 7th Annual Charlotte Biotechnology Conference (www.CharlotteBiotechnology.co taking place at the Barnhardt Student Activities Center on October 28, 2008. This flagship conference represents the region's top biotechnology thought leaders in research, investment, education, economic development ... (Wed, 01 Oct 2008 20:12:03 GMT)
New Research Shows MicroRNAs Emerged Early in Evolution
Scientists have long wondered when the tiny gene-tweaking molecules known as microRNAs first arose during animal evolution. Their curiosity has been driven, in part, by lingering questions about whether these snippets of RNA helped shape the development of complex multi-cellular animals. (Wed, 01 Oct 2008 20:34:57 GMT)
Use it or lose it? Researchers investigate the dispensability of our DNA
( Cold Spring Harbor Laboratory ) Our genome contains many genes encoding proteins that are similar to those of other organisms, suggesting evolutionary relationships; however, protein-coding genes account for a small fraction the genome, and there are many other DNA sequences that are conserved across species. What are these sequences doing? Do we really need them? In a study published online ... (Wed, 01 Oct 2008 21:12:18 GMT)
Luminex Corporation Hosts Sixth Annual Planet xMap Europe 2008 Symposium
OOSTERHOUT, The Netherlands----Luminex Corporation , the worldwide leader in multiplexed solutions, today announced the agenda for Planet xMAP Europe 2008, the company's annual European multiplexing technology symposium, which will be held 8-9 October, at Beurs van Berlage in Amsterdam. (Wed, 01 Oct 2008 22:02:00 GMT)
Luminex Corporation Hosts Sixth Annual Planet xMap Europe 2008 Symposium
Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced the agenda for Planet xMAP Europe 2008, the company's annual European multiplexing technology symposium, which will be held 8-9 October, at Beurs van Berlage in Amsterdam. The two-day event will include workshops, presentations, scientific posters and networking events. The symposium is a gathering ... (Wed, 01 Oct 2008 22:26:53 GMT)
Luminex Corporation Hosts Sixth Annual Planet xMap Europe 2008 Symposium
Luminex Corporation (9295;NASDAQ:LMNX), the worldwide leader in multiplexed solutions, today announced (Wed, 01 Oct 2008 22:33:16 GMT)
Saliva Proteins Could Help Detection Of Oral Cancer
Clinicians could detect oral squamous cell carcinoma, a form of oral cancer, using a simple test that detects proteins in saliva, according to a report in the Oct. 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. This work was led by David T. Wong, D.M.D., D.M.Sc., professor and associate dean for research, at the University of California, ... (Thu, 02 Oct 2008 04:22:41 GMT)
New Genes Linked To Gout
Researchers have identified two new genes -- and confirmed the role of a third gene -- associated with increased risk of higher levels of uric acid in the blood, which can lead to gout, a common, painful form of arthritis. Combined, the three genetic variations were associated with up to a 40-fold increased risk in developing gout. (Thu, 02 Oct 2008 04:23:41 GMT)
SAIC Wins $5.2bn NCI Contract
Science Applications International Corp. has said that its subsidiary SAIC-Frederick Inc. has won a 10-year, $5.2bn contract to help operate and provide technical support to the National Cancer Institute's research and development center in Frederick. (Thu, 02 Oct 2008 05:43:47 GMT)
New Signature Names Dave Charlton COO
Dave Charlton joined New Signature as COO on September 22nd, 2008. In this role, Dave will direct the technical efforts of New Signature's creative team, lead client initiatives, manage the day-to-day activities of the corporation, and guide corporate planning and development. Dave has over fifteen years of experience in leadership positions with established public companies and startups. (Thu, 02 Oct 2008 07:01:00 GMT)
Researcher honoured
A University of New Brunswick professor was honoured Wednesday night for his commercially driven research. (Thu, 02 Oct 2008 09:08:00 GMT)
Simple saliva test could help detect oral cancer
Washington, Oct 1 : A simple test of saliva proteins could soon help doctors in detecting oral squamous cell carcinoma, a form of oral cancer, according to a new study. (Thu, 02 Oct 2008 10:31:34 GMT)
Saliva Proteins Could Help Detection Of Oral Cancer
Clinicians could detect oral squamous cell carcinoma, a form of oral cancer, using a simple test that detects proteins in saliva, according to a report in the October 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. This work was led by David T. Wong, D.M.D., D.M.Sc. (Thu, 02 Oct 2008 11:06:31 GMT)
Discovery Of New Genes Linked To Gout
Researchers have identified two new genes - and confirmed the role of a third gene - associated with increased risk of higher levels of uric acid in the blood, which can lead to gout, a common, painful form of arthritis. Combined, the three genetic variations were associated with up to a 40-fold increased risk in developing gout. (Thu, 02 Oct 2008 11:07:41 GMT)
WaferGen to Present at BioMalaysia 2008
WaferGen Biosystems, Inc. , a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced that Alnoor Shivji, WaferGen's president and chief executive officer, will deliver a presentation entitled, "Genomics and Stem Cell Research -- Catalyst to Biotech Growth in Malaysia," at BioMalaysia 2008. (Thu, 02 Oct 2008 11:30:00 GMT)
Emerging Model Organisms Featured In CSH Protocols
Biological research has long relied on a small number of model organisms, species chosen because they are amenable to laboratory research and suitable for the study of a range of biological problems. (Thu, 02 Oct 2008 12:07:11 GMT)
Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay
Rosetta Genomics, Ltd. , a leader in the development of microRNA-based diagnostic and therapeutic products, announced today the initiation of a clinical assessment study with the Johns Hopkins University School of Medicine. (Thu, 02 Oct 2008 12:30:00 GMT)
Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay
Rosetta Genomics, Ltd. , a leader in the development of microRNA-based diagnostic and therapeutic products, announced today the initiation of a clinical assessment study with the Johns Hopkins University School of Medicine. (Thu, 02 Oct 2008 12:30:00 GMT)
RTP-based BioMedomics wins $750K SBIR grant
RESEARCH TRIANGLE PARK, NC – BioMedomics, a privately held biotechnology company developing advanced medical diagnostics tools for use in personalized medicine, has received a $750,000 Phase II Small Business Innovation Research (SBIR) contract from the National Institutes of Health. (Thu, 02 Oct 2008 13:02:28 GMT)
23andMe Announces Breast Cancer Initiative
based Community For Women Impacted by Breast Cancer (Thu, 02 Oct 2008 13:58:00 GMT)
CLC bio Partners with Illumina to Provide Next Generation Sequencing Analysis Technology
AARHUS, Denmark----Following an overwhelming reception of CLC Genomics Workbench 1.0, CLC bio is happy to announce the release of its next major version of their flagship product: CLC Genomics Workbench 2.0. (Thu, 02 Oct 2008 14:41:00 GMT)
CLC bio Partners with Illumina to Provide Next Generation Sequencing Analysis Technology
Following an overwhelming reception of CLC Genomics Workbench 1.0, CLC bio is happy to announce the release of its next major version of their flagship product: CLC Genomics Workbench 2.0. Additionally, CLC bio has taken another important step in leading next generation sequencing data analysis by becoming an Illumina Connect partner. Illumina Connect is a bioinformatics software partnership ... (Thu, 02 Oct 2008 14:57:23 GMT)
Johns Hopkins to Evaluate Rosetta Genomics' Lung miRNA Cancer Diagnostic
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Thu, 02 Oct 2008 15:02:52 GMT)
CLC Joins Illumina Bioinformatics Partnering Program
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Thu, 02 Oct 2008 15:03:12 GMT)
'Reprioritise' genetic goals, developing nations told
[HYDERABAD] Developing countries need to review their research priorities in genomics and not blindly adopt developed countries' focus on complex lifestyle-related disorders, cautions an expert. (Thu, 02 Oct 2008 17:11:12 GMT)
19th International Symposium on Human Identification Features Advances and Applications in DNA Testing
The expanding power of DNA analysis is a key focus of this year's 19th International Symposium on Human Identification hosted by Promega Corporation. This year, keynote speaker, Dr. Sean Carroll will discuss the utility of DNA as the "Ultimate Record of Evolution." Additional presentations will feature methods used to identify the slain children of Czar Nicholas who were murdered during the ... (Thu, 02 Oct 2008 19:31:50 GMT)
Friday, October 3, 2008
Bharat Sanchar Nigam Limited: Award presentation of Vishist Sanchar Seva Padak, T V Srirangan, Member P and T Board, T S Kuppuswamy, Chief General Manager, Karnataka Telecom Circle to preside, Chowdiah Memorial Hall, Vyalikaval, 4.30 pm. (Thu, 02 Oct 2008 21:42:15 GMT)
Invitrogen Sets Third Quarter Earnings Release Date for Tuesday, October 21, 2008
CARLSBAD, Calif.----Invitrogen Corporation , a provider of essential life science technologies for research, production and diagnostics, will announce its third quarter 2008 earnings on Tuesday, October 21, 2008, after Market close. (Thu, 02 Oct 2008 23:43:00 GMT)
Invitrogen Sets Third Quarter Earnings Release Date for Tuesday, October 21, 2008
Invitrogen Corporation (8208;NASDAQ:IVGN), a provider of essential life science technologies for research, (Thu, 02 Oct 2008 23:48:06 GMT)
Invitrogen Sets Third Quarter Earnings Release Date for Tuesday, October 21, 2008
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, will announce its third quarter 2008 earnings on Tuesday, October 21, 2008, after Market close. Following the earnings release, Invitrogen senior management will hold a live webcast at 4:30 p.m. EDT to discuss the financial and business results in more detail. (Thu, 02 Oct 2008 23:56:41 GMT)
Minerva Biotechnologies Announces Major Stem Cell Breakthrough
Minerva Biotechnologies, a leading nanotechnology, cancer and stem cell development company today announced a major breakthrough in stem cell research. Minerva and collaborators at the University of California at Santa Barbara discovered that a single, new growth factor can not only support massive growth of human embryonic stem cells (hESCs) in vitro, but also maintains them in a nearly 100% ... (Fri, 03 Oct 2008 00:27:01 GMT)
SurModics acquires CodeLink activated slide business from GE Healthcare
SurModics, a provider of surface modification and drug delivery technologies to the healthcare industry, has acquired the CodeLink activated slide microarray business from GE Healthcare. Terms of the transaction were not disclosed. (Fri, 03 Oct 2008 00:36:42 GMT)
What HIV Needs: Identification Of Human Factors May Yield Novel Therapeutic Targets For HIV
Scientists have found 295 host cell factors that are involved in human immunodeficiency virus infection. Their research could lead to the development of a new class of HIV therapeutics aimed at disrupting the human-HIV interactions that lead to viral infection. (Fri, 03 Oct 2008 03:24:41 GMT)
Dietrich Stephan
Why Is He Famous? Dietrich Stephan is a brilliant genetic scientist who has slowly but surely moved to the forefront of the fight against deadly genetic diseases, as his work has proven instrumental in identifying genes that lead directly to such disorders as autism and even heart attacks. (Fri, 03 Oct 2008 04:11:58 GMT)
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics ...
Cell Therapeutics, Inc. announced today that Christina A. Waters, Ph.D., M.B.A., most recently President and COO of a Tyr Pharma and formerly Director of Scientific Development at Genomics Institute of the Novartis Research Foundation, has been named President of CTI Europe. (Fri, 03 Oct 2008 10:00:00 GMT)
CombiMatrix to Hold Conference Call to Discuss the Development of Array for Cancer Screening
MUKILTEO, Wash., Oct. 3, 2008 -- CombiMatrix Corporation will hold a conference call to discuss the development of its CombiMatrix Cancer Array test for cancer screening. Dr. Amit Kumar, President and CEO of CombiMatrix will host this call and will make a short presentation, followed by Q&A. (Fri, 03 Oct 2008 10:00:00 GMT)
Johns Hopkins University Researchers To Clinically Assess Rosetta Genomics' MiRview(TM) Squamous Assay
Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic products, announced today the initiation of a clinical assessment study with the Johns Hopkins University School of Medicine. (Fri, 03 Oct 2008 10:06:41 GMT)
Wall Street Journal Selects PhyloChip Developed on the Affymetrix Platform as a Top Technology Innovation
SANTA CLARA, Calif.----Affymetrix Inc. announced today that the PhyloChip, a custom Affymetrix microarray developed by Lawrence Berkeley National Laboratory, won the bronze prize in the 2008 Wall Street Journal Technology Innovation Awards. (Fri, 03 Oct 2008 12:00:00 GMT)
Wall Street Journal Selects PhyloChip Developed on the Affymetrix Platform as a Top Technology Innovation
Affymetrix Inc. (Nasdaq:AFFX) announced today that the PhyloChip, a custom Affymetrix microarray developed by Lawrence Berkeley National Laboratory, won the bronze prize in the 2008 Wall Street Journal Technology Innovation Awards. The PhyloChip helps researchers identify dangerous pathogens before they can affect humans. The PhyloChip was the only biotech company in the top three to be ... (Fri, 03 Oct 2008 12:27:30 GMT)
Saliva Proteins May Help Spot Oral Cancer
FRIDAY, Oct. 3 (HealthDay News) -- A simple test of saliva proteins may one day help doctors detect oral cancer, according to a new study in the Oct. 1 issue of Clinical Cancer Research. (Fri, 03 Oct 2008 13:01:35 GMT)
FDA Awards Up To $2.5 Billion To Modernize Information Technology Over Ten Years - Cornerstone Of 21st Century ...
The U.S. Food and Drug Administration today announced the selection of ten contractors to receive up to a total of $2.5 billion for information technology (IT) and data center management services over the next ten years. (Fri, 03 Oct 2008 13:08:22 GMT)
Minerva Biotechnologies Announces Major Stem Cell Breakthrough
Minerva Biotechnologies, a leading nanotechnology, cancer and stem cell development company today announced a major breakthrough in stem cell research. (Fri, 03 Oct 2008 16:06:41 GMT)
Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
( Mary Ann Liebert, Inc./Genetic Engineering News ) Novel platform technologies and key advances in genomics are rapidly driving the development of molecular diagnostics, reports Genetic Engineering and Biotechnology News. The payoff for successful molecular diagnostic products can be significant as Kalorama Information predicts that this market currently exceeds $3.2 billion worldwide and will ... (Fri, 03 Oct 2008 18:55:56 GMT)
Friday, October 3, 2008
Bharat Sanchar Nigam Limited: Award presentation of Vishist Sanchar Seva Padak, T V Srirangan, Member P and T Board, T S Kuppuswamy, Chief General Manager, Karnataka Telecom Circle to preside, Chowdiah Memorial Hall, Vyalikaval, 4.30 pm. (Fri, 03 Oct 2008 22:08:29 GMT)
Growing Role Of Molecular Diagnostics
Novel platform technologies and key advances in genomics are rapidly driving the development of molecular diagnostics, reports Genetic Engineering and Biotechnology News. The payoff for successful molecular diagnostic products can be significant as Kalorama Information predicts that this market currently exceeds $3.2 billion worldwide and will reach $5.4 billion in four years. (Fri, 03 Oct 2008 22:21:21 GMT)
Ridley teacher awarded molecular biology teaching prize
When students in Bob Malyk’s biology class pick up a newspaper some day and see advances made in treating deafness or addictions, they’ll feel a [...] (Sat, 04 Oct 2008 02:27:09 GMT)
US FDA selects 10 contractors for $2.5 bn IT & data centre modernisation
The US Food and Drug Administration announced the selection of ten contractors to receive up to a total of $2.5 billion for information technology (IT) and data centre management services over the next ten years. (Sat, 04 Oct 2008 05:47:59 GMT)
Molecular diagnostics now hottest biotechnology tool
Washington, Oct 4 : Key advances in genomics, supported by cutting-edge technologies, are rapidly driving the development of molecular diagnostics, according to a report. (Sat, 04 Oct 2008 08:14:21 GMT)
Women getting ready to lead
Businesswomen, entrepreneurs and students are getting ready for a pilgrimage to downtown Buffalo on Tuesday. (Sat, 04 Oct 2008 10:47:05 GMT)
Your family history
This is the final article in a series of four by the Cancer Research Initiatives Foundation (CARIF) that explores how genes are linked to diseases. This week, we explore the importance of an individual’s family history in assessing the need for genetic testing, and the role of experts in providing information and services in the process. (Sun, 05 Oct 2008 00:39:31 GMT)
Dreams taking shape
Dr. Glover O.L. Johnson has a dream for Cleveland — to establish a biomedical research institute that rivals that best medical schools in the United States. On Saturday at the ZaZa Hotel in Houston, he shared his dream with 350 or so people at a gala to benefit the Southeast Texas Biomedical Research Institute (SETBRI). (Sun, 05 Oct 2008 07:48:46 GMT)
19th International Symposium On Human Identification Features Advances And Applications In DNA Testing
The expanding power of DNA analysis is a key focus of this year's 19th International Symposium on Human Identification hosted by Promega Corporation. This year, keynote speaker, Dr. Sean Carroll will discuss the utility of DNA as the "Ultimate Record of Evolution. (Sun, 05 Oct 2008 14:06:51 GMT)
Dreams taking shape
Dr. Glover O.L. Johnson has a dream for Cleveland — to establish a biomedical research institute that rivals that best medical schools in the United States. On Saturday at the ZaZa Hotel in Houston, he shared his dream with 350 or so people at a gala to benefit the Southeast Texas Biomedical Research Institute (SETBRI). (Sun, 05 Oct 2008 15:41:48 GMT)
Mergers and acquisitions
Mergers and acquisitions involving Minnesota companies that were announced in the past week. 9/30 CommtechWireless Amcom Software Amcom acquired the provider of technology Jacksonville, Fla. Minneapolis that connects critical data sources. 9/30 Codelink Activated Slide SurModics Inc. (Mon, 06 Oct 2008 01:55:45 GMT)
Dawn of Low-Price Mapping Could Broaden DNA Uses
A start-up company called Complete Genomics says it will start charging $5,000 next year to determine a person?s complete genetic blueprint. (Mon, 06 Oct 2008 04:13:07 GMT)
Dreams taking shape
Dr. Glover O.L. Johnson has a dream for Cleveland — to establish a biomedical research institute that rivals that best medical schools in the United States. On Saturday at the ZaZa Hotel in Houston, he shared his dream with 350 or so people at a gala to benefit the Southeast Texas Biomedical Research Institute (SETBRI). (Mon, 06 Oct 2008 05:56:34 GMT)
This Week
Prime Minister Costas Karamanlis visits Evian, France, to attend the World Policy Conference. To tomorrow. The Education Ministry is hosting a conference on “Animals and Children: Residents of the Same Planet,” starting at 10 a.m. at the ministry. For more information, log on to www.ypepth.gr. (Mon, 06 Oct 2008 08:21:47 GMT)
CLC bio partners with Illumina to provide next generation sequencing data analysis technology
Following an overwhelming reception of CLC Genomics Workbench 1.0, CLC bio announced the release of its next major version of their flagship product: CLC Genomics Workbench 2.0. Additionally, CLC bio has taken another important step in leading next generation sequencing data analysis by becoming an Illumina Connect partner. (Mon, 06 Oct 2008 08:47:59 GMT)
Growing Role Of Molecular Diagnostics Reported In Genetic Engineering & Biotechnology News
Novel platform technologies and key advances in genomics are rapidly driving the development of molecular diagnostics, reports Genetic Engineering and Biotechnology News (GEN). The payoff for successful molecular diagnostic products can be significant as Kalorama Information predicts that this market currently exceeds $3.2 billion worldwide and will reach $5. (Mon, 06 Oct 2008 10:07:34 GMT)
Dawn of Low-Price Mapping Could Broaden DNA Uses
A start-up company called Complete Genomics says it will start charging $5,000 next year to determine a persons complete genetic blueprint. (Mon, 06 Oct 2008 11:10:54 GMT)
Start-Up Offers Lower-Price DNA Mapping
The cost of determining a person’s complete genetic blueprint is about to plummet again — to $5,000. That is the price that a start-up company called Complete Genomics says it will start charging next year for determining the sequence of the genetic code that makes up the DNA in one set of human chromosomes. (Mon, 06 Oct 2008 11:19:05 GMT)
Complete Genomics Launches, Becomes World's First Large-Scale Human Genome Sequencing Company
Complete Genomics Inc., a third-generation human genome sequencing company, today announced its formal launch as the world's first provider of large-scale human genome sequencing services. (Mon, 06 Oct 2008 12:00:00 GMT)
Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome ...
Complete Genomics Inc., a newly launched, third-generation human genome sequencing company, and the Institute for Systems Biology today announced their partnership to conduct populationwide human genome studies. (Mon, 06 Oct 2008 12:00:00 GMT)
Five Thousand Bucks for Your Genome
A new sequencing service could change the face of human genomics. (Mon, 06 Oct 2008 12:14:39 GMT)
James A. Fagin, MD Elected to Board of Directors of the American Thyroid Association
James A. Fagin, MD of New York, NY, has been elected as a director on the board of the American Thyroid Association (ATA). He will serve a four-year term of office (2008-2012). (Mon, 06 Oct 2008 13:21:07 GMT)
Dawn of Low-Price Mapping Could Broaden DNA Uses
A start-up company called Complete Genomics says it will start charging $5,000 next year to determine a person?s complete genetic blueprint. (Mon, 06 Oct 2008 13:38:35 GMT)
Dawn of Low-Price Mapping Could Broaden DNA Uses
A start-up company called Complete Genomics says it will start charging $5,000 next year to determine a persons complete genetic blueprint. (Mon, 06 Oct 2008 13:42:48 GMT)
Complete Genomics, ISB To Collaborate on Genome Studies; Firm Targets $5K Genome for 2009
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Mon, 06 Oct 2008 14:17:52 GMT)
Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract
Caprion Proteomics Inc. announced today that it has been awarded a $12.9 million contract by the National Institute of Allergy and Infectious Diseases , a part of the US National Institutes of Health, to carry out Biodefense research in the area of infectious disease biomarkers. (Mon, 06 Oct 2008 14:47:00 GMT)
Complete Genomics launches, becomes world's first large-scale human genome sequencing company
( Complete Genomics ) Complete Genomics launched today as the world's first provider of large-scale human genome sequencing services. Complete Genomics plans to combine its proprietary third-generation DNA sequencing technology and its high-performance computing capabilities to create a human genome sequencing service that will deliver low-cost, high-quality data on an unprecedented scale. It ... (Mon, 06 Oct 2008 14:55:47 GMT)
Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract
Caprion Proteomics Inc. announced today that it has been awarded a $12.9 million contract by the National Institute of Allergy and Infectious Diseases , a part of the US National Institutes of Health, to carry out Biodefense research in the area of infectious disease biomarkers. (Mon, 06 Oct 2008 15:08:00 GMT)
Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract
Caprion Proteomics Inc. announced today that it has been awarded a US$12.9 million contract by the National Institute of Allergy and Infectious Diseases , a part of the US National Institutes of Health, to carry out Biodefense research in the area of infectious disease biomarkers. (Mon, 06 Oct 2008 15:25:00 GMT)
Signature Genomic Laboratories Announces Appointment of New Laboratory Director
Signature Genomic Laboratories has appointed Roger Schultz, Ph.D., as Laboratory Director. (Mon, 06 Oct 2008 16:17:00 GMT)
New Tech Could Change Genetic Research
A new genome-sequencing service could change the face of human genomics. (Mon, 06 Oct 2008 16:31:30 GMT)
Saliva Proteins May Help Spot Oral Cancer
Title: Saliva Proteins May Help Spot Oral Cancer Category: Health News Created: 10/4/2008 2:00:00 AM Last Editorial Review: 10/6/2008 (Mon, 06 Oct 2008 19:31:16 GMT)
Complete Genomics emerges from stealth
Third-generation human genome sequencing company Complete Genomics Inc. announced its launch on Monday. (DNA) (Mon, 06 Oct 2008 19:52:21 GMT)
Leading Proxy Advisory Firms Recommend That Invitrogen and Applied Biosystems Shareholders Approve Merger
CARLSBAD, Calif. & FOSTER CITY, Calif.----Invitrogen Corporation and Applied Biosystems Inc. today announced that RiskMetrics Group, formerly known as Institutional Shareholder Services, or ISS, Glass Lewis & Co. and PROXY Governance, Inc., have all recommended that Invitrogen and Applied Biosystems shareholders vote FOR the proposed merger at each company's respective special meeting of ... (Mon, 06 Oct 2008 20:03:00 GMT)
Leading Proxy Advisory Firms Recommend That Invitrogen and Applied Biosystems Shareholders Approve Merger
Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced that RiskMetrics Group, formerly known as Institutional Shareholder Services, or ISS, Glass Lewis & Co. and PROXY Governance, Inc., have all recommended that Invitrogen and Applied Biosystems shareholders vote FOR the proposed merger at each company's respective special meeting of shareholders. (Mon, 06 Oct 2008 20:26:31 GMT)
Nobel Prize to HPV Researcher Highlights Importance of Cervical Cancer Screening and Prevention
The Nobel Prize-winning discovery of the causal link between human papillomavirus and cervical cancer has spurred lifesaving prevention technologies -- such as HPV testing and HPV vaccines -- that are helping to eradicate cervical cancer globally. (Mon, 06 Oct 2008 20:51:00 GMT)
$5,000 genome next year, company promises
Complete Genomics is about to release fast, cheap sequencing into a competitive market. (Mon, 06 Oct 2008 21:54:08 GMT)
Ronald Mirman: U.S. Space Policy = Waste As Much Money As Possible
Both Barack Obama and John McCain have spoken on space policy, and both are wrong. McCain is clearly more interested (he was a pilot and... (Tue, 07 Oct 2008 00:42:25 GMT)
New Self-training Gene Prediction Program For Fungi Developed
Researchers have developed a computer program that trains itself to predict genes in the DNA sequences of fungi. The software will be freely available for academic researchers. (Tue, 07 Oct 2008 02:21:51 GMT)
LSUS program targets movie production
A new animation and visual effects program aims to train a workforce of digital media artists for work on movies, TV projects and videogames. The program's supported by $800,000 in state money. (Tue, 07 Oct 2008 07:07:33 GMT)
Researchers working on cancer detection blood test
Researchers are working on a simple blood test to detect cancer a year before symptoms develop. (Tue, 07 Oct 2008 07:09:31 GMT)
Links
The challenges are identified in a draft strategic plan outlining the agency's work for the next five years. (Tue, 07 Oct 2008 07:09:57 GMT)
Enza Chooses Fluidigm BioMark System to Help Assure Core Seed Quality
Fluidigm Corporation and BIOKE, a licensed distributor for the company, today announced that Enza Zaden, one of the world's leading suppliers of high-quality vegetable seeds for agriculture, has chosen the Fluidigm's BioMark(TM) System for Genetic Engineering and the new 96.96 Dynamic Array to help assure the quality of its seed supply. (Tue, 07 Oct 2008 07:11:31 GMT)
So, CTO, who's your Sarah Palin or Joe Biden?
Even in the nuts-and-bolts world of tech execs, choosing a right-hand man (or woman, of course) can be as politically challenging as anything going on in the halls of Washington, D.C. (Tue, 07 Oct 2008 10:00:00 GMT)
Isilon CTO Addresses Life Science Data Storage Challenges at Harvard Medical School's BioMedical HPC Leadership Summit
Isilon® Systems , the leader in clustered storage, today announced that Isilon Chief Technology Officer Paul Rutherford will address the growing data storage challenges facing life science research organizations as part of the Harvard Medical School's BioMedical HPC Leadership Summit, October 5-7, in Cambridge, Massachusetts. (Tue, 07 Oct 2008 10:00:00 GMT)
AsiaNet Daily Summary - Press Releases for Tuesday, Oct. 7, 2008
Çѹ·Õè 7 µØÅÒ¤Á 2551 17:10 ¹. SURRENDA-LINK... CHESTER - Surrenda-link Investment Management, Europe's premier traded life policy investment specialist(1), has received soaring levels of enquiries from institutional investors regarding US Life Settlement investments. (Tue, 07 Oct 2008 10:18:28 GMT)
SQI Diagnostics Announces Appointment of Senior VP, Sales and Marketing
SQI Diagnostics Inc. , a medical systems automation company focused on evolving laboratory-based biomarker testing, announced today that Thomas O'Connor has been appointed the Company's Senior Vice President, Sales and Marketing. (Tue, 07 Oct 2008 11:00:00 GMT)
Roche NimbleGen Multiplex CGH Arrays Enable Detection of Exonic Deletions and Duplications Associated with Muscular ...
MADISON, Wis----Researchers from France investigating DNA copy number changes associated with genetic disorders have reported the development and validation of a Roche NimbleGen CGH multiplex, microarray-based research method for detecting genomic deletions and duplications at high-resolution. (Tue, 07 Oct 2008 12:00:00 GMT)
MDRNA, Inc. Advances RNAi Pipeline With Selection of Lead Candidate for Hypercholesterolemia Program
MDRNA, Inc. announced today that it has advanced its RNAi pipeline with the selection of a Lead Candidate in its hypercholesterolemia program targeting Apolipoprotein B. The compound, designated MDR-04227, was developed using MDRNA's propriety drug discovery engine, which is built on a broad and enabling intellectual property estate and an in-house novel and proprietary delivery technology. (Tue, 07 Oct 2008 12:00:00 GMT)
South African Core Lab Adopts Affymetrix Technology for Genomic Studies
SANTA CLARA, Calif.----Affymetrix Inc., today announced that one of South Africa’s largest public core labs has begun offering genomic research on the Affymetrix GeneChip® platform. (Tue, 07 Oct 2008 12:00:00 GMT)
NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies
FORT WASHINGTON, Pa.----The National Comprehensive Cancer Network , Abraxis BioScience , and AstraZeneca today announced that they have entered into a collaboration to conduct multiple investigator-initiated studies of Abraxis BioScience's anti-cancer drug ABRAXANE® for Injectable Suspension , which is based on the company's proprietary tumor targeting technology known as the nab™ platform. (Tue, 07 Oct 2008 13:00:00 GMT)
Invitrogen Files Merger Notification With European Commission
CARLSBAD, Calif.----Invitrogen Corporation today announced that it has filed the necessary formal notification to the European Commission with respect to its pending acquisition of Applied Biosystems Inc. . (Tue, 07 Oct 2008 13:00:00 GMT)
CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of ...
CEL-SCI Corporation announced today that it has entered into a Material Transfer Agreement with the National Institutes of Health Clinical Center and the laboratory of Dr. Francesco M. (Tue, 07 Oct 2008 14:34:00 GMT)
South Africa's CPGR Begins Offering Services Using Affymetrix Microarray Platform
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 07 Oct 2008 15:03:27 GMT)
UB tapped for HIV/AIDS work
The University at Buffalo has received a new $7.6 contract that will help enable high quality clinical trials for HIV/AIDS researchers around the world. (Tue, 07 Oct 2008 15:08:29 GMT)
Arrayit - BSI Alliance Provides New Research Technology to Identify Disease Diagnostics
Integrated Media Holdings, Inc. announced today that its wholly owned subsidiary, TeleChem International, Inc. doing business as Arrayit Company, has entered into an exclusive agreement with BioSystems International SAS for the supply and license rights to produce state-of-the-art microarrays featuring antibodies that identify proteins uniquely expressed in human plasma. The Human Plasma ... (Tue, 07 Oct 2008 16:16:00 GMT)
Company To Sequence 1,000 Human Genomes In 2009 For $5,000 Each
Complete Genomics Inc., a third-generation human genome sequencing company, has announced its formal launch as the world's first provider of large-scale human genome sequencing services. The company, which was established in March 2006, has been operating in "stealth mode" from a 32,000-square-foot facility near San Francisco. (Tue, 07 Oct 2008 19:09:22 GMT)
Telechem, BioSystems International to Collaborate on Proteome Microarray
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 07 Oct 2008 20:48:22 GMT)
So, CTO, Who's Your Sarah Palin or Joe Biden?
For IT, the choice of a deputy matters a great deal. So how do you get the right one? (Tue, 07 Oct 2008 21:12:46 GMT)
Enza Zaden chooses Fluidigm BioMark system to help assure core seed quality
Fluidigm Corporation and BIOKÉ , a licensed distributor for the company, today announced that Enza Zaden , one of the world’s leading suppliers of high-quality vegetable seeds for agriculture, has chosen the Fluidigm’s BioMark™ System for Genetic Engineering and the new 96.96 Dynamic Array to help assure the quality of its seed supply. (Tue, 07 Oct 2008 21:26:06 GMT)
UB Receives $7.6 Million Grant
The University at Buffalo is receiving a multi-million dollar contract in the worldwide fight against HIV and Aids. Details of the contract were released Tuesday morning at the Center for Excellence in Bioinformatics and Life Sciences. (Wed, 08 Oct 2008 00:18:09 GMT)
Caprion wins $12.9 million biomarker research contract from NIAID
Caprion Proteomics, a provider of proteomics based services to the pharmaceutical industry, has received a $12.9 million contract form the National Institute of Allergy and Infectious Diseases, a part of the US National Institutes of Health, to carry out biodefense research in the area of infectious disease biomarkers. (Wed, 08 Oct 2008 00:41:14 GMT)
RO 5.2m Genetic Centre coming up at Bausher
08 October 2008 MUSCAT -- The RO 5.2 million National Genetic Centre (NGC) coming up at Bausher Wilayat near Royal Hospital will enable the Ministry of Health to extend the potential health benefits of the genomics advances to people. (Wed, 08 Oct 2008 06:54:10 GMT)
Nonlinear Dynamics' Progenesis analysis software is chosen by Boston University's Cardiovascular Proteomics Center ...
NEWCASTLE UPON TYNE, England----Nonlinear Dynamics Ltd, the world leading developer of analysis solutions for proteomics and biomarker discovery, has announced that Boston University's Cardiovascular Proteomics Center Core Laboratory have chosen the Progenesis software range for their label free LC-MS and 2D data analyses. (Wed, 08 Oct 2008 09:49:00 GMT)
Complete Genomics and ISB form partnership
Complete Genomics, a newly launched, third-generation human genome sequencing company, and the Institute for Systems Biology have announced their partnership to conduct populationwide human genome studies. (Wed, 08 Oct 2008 09:52:13 GMT)
Webcast On CombiMatrix's Comprehensive Cancer Array Available On Website
MUKILTEO, Wash., Oct. 8, 2008 -- CombiMatrix Corporation held a web-broadcast on October 7, 2008 to discuss its development of a Comprehensive Cancer Array test for the non-invasive screening of multiple cancers simultaneously. (Wed, 08 Oct 2008 10:00:00 GMT)
CEL-SCI Enters Agreement With National Institutes Of Health Clinical Center To Determine The Molecular Basis Of ...
CEL-SCI Corporation (NYSE: CVM) announced that it has entered into a Material Transfer Agreement (MTA) with the National Institutes of Health Clinical Center (NIHCC) and the laboratory of Dr. Francesco M. Marincola, M.D., to investigate the molecular basis of changes to the tumor microenvironment caused by CEL-SCI's cancer drug Multikine. Dr. (Wed, 08 Oct 2008 10:06:11 GMT)
UK PubMed goes beyond journals
Tracey Caldwell, Best known as an access gateway to biomedical research journals, the UK incarnation of the PubMed Central website is to introduce access to additional types of content, such as clinical... (Wed, 08 Oct 2008 10:52:32 GMT)
UB awarded grant to fight against global AIDS epidemic
Buffalo will play a vital international role in the fight against the global AIDS epidemic. (Wed, 08 Oct 2008 11:20:22 GMT)
Invitrogen Redesigns GIBCO(R) Bottle to Improve Form and Function
CARLSBAD, Calif.----Invitrogen Corporation , a provider of essential life science technologies for research, production and diagnostics, announced the global launch of its updated GIBCO cell culture media bottles. (Wed, 08 Oct 2008 12:03:00 GMT)
Searching for Intelligence in Our Genes
In Robert Plomin’s line of work, patience is essential. Plomin, a behavioral geneticist at the Institute of Psychiatry in London, wants to understand the nature of intelligence. As part of his research, he has been watching thousands of children grow up. Plomin asks the children questions such as “What do water and milk have in common?” and “In what direction does the sun set?” At first he and ... (Wed, 08 Oct 2008 12:03:40 GMT)
New Lab Manual Focuses On Essential Methods For Purifying And Characterizing Proteins
A new, user-friendly laboratory manual for protein purification and analysis has just been released by Cold Spring Harbor Laboratory Press. (Wed, 08 Oct 2008 12:07:51 GMT)
Pathwork Diagnostics Announces Key Additions to Management Team
Pathwork Diagnostics, a molecular diagnostics company focused on oncology, announced today the appointment of two key positions within the company's management team, Fletcher Payne as Chief Financial Officer and Mark McDonough as Vice President of US Sales. (Wed, 08 Oct 2008 14:00:00 GMT)
Boston U Proteomics Lab Using Nonlinear Dynamics' Analysis Software
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 08 Oct 2008 14:48:12 GMT)
1 2 3 4 5 Next
